PERRIGO CO PLC (PRGO)

IE00BGH1M568 - Common Stock

25.75  +0.02 (+0.08%)

After market: 25.75 0 (0%)

Fundamental Rating

4

Overall PRGO gets a fundamental rating of 4 out of 10. We evaluated PRGO against 193 industry peers in the Pharmaceuticals industry. PRGO has an average financial health and profitability rating. PRGO has a bad growth rate and is valued cheaply.



4

1. Profitability

1.1 Basic Checks

In the past year PRGO was profitable.
In the past year PRGO had a positive cash flow from operations.
In the past 5 years PRGO reported 4 times negative net income.
PRGO had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of PRGO (-1.43%) is better than 80.63% of its industry peers.
PRGO has a Return On Equity of -3.50%. This is amongst the best in the industry. PRGO outperforms 82.20% of its industry peers.
PRGO has a Return On Invested Capital of 1.93%. This is in the better half of the industry: PRGO outperforms 79.58% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PRGO is significantly below the industry average of 43.18%.
Industry RankSector Rank
ROA -1.43%
ROE -3.5%
ROIC 1.93%
ROA(3y)-0.68%
ROA(5y)-0.44%
ROE(3y)-1.5%
ROE(5y)-0.97%
ROIC(3y)3.16%
ROIC(5y)2.69%

1.3 Margins

PRGO has a better Operating Margin (5.42%) than 79.06% of its industry peers.
In the last couple of years the Operating Margin of PRGO has declined.
PRGO has a Gross Margin (36.07%) which is in line with its industry peers.
In the last couple of years the Gross Margin of PRGO has remained more or less at the same level.
Industry RankSector Rank
OM 5.42%
PM (TTM) N/A
GM 36.07%
OM growth 3Y-2.94%
OM growth 5Y-9.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.43%
GM growth 5Y-1.39%

4

2. Health

2.1 Basic Checks

PRGO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PRGO has more shares outstanding than it did 1 year ago.
PRGO has less shares outstanding than it did 5 years ago.
PRGO has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.75, we must say that PRGO is in the distress zone and has some risk of bankruptcy.
PRGO's Altman-Z score of 0.75 is in line compared to the rest of the industry. PRGO outperforms 57.07% of its industry peers.
The Debt to FCF ratio of PRGO is 31.33, which is on the high side as it means it would take PRGO, 31.33 years of fcf income to pay off all of its debts.
PRGO has a better Debt to FCF ratio (31.33) than 78.53% of its industry peers.
A Debt/Equity ratio of 0.94 indicates that PRGO is somewhat dependend on debt financing.
PRGO has a Debt to Equity ratio of 0.94. This is in the lower half of the industry: PRGO underperforms 72.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 31.33
Altman-Z 0.75
ROIC/WACC0.3
WACC6.46%

2.3 Liquidity

PRGO has a Current Ratio of 2.56. This indicates that PRGO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PRGO (2.56) is comparable to the rest of the industry.
PRGO has a Quick Ratio of 1.77. This is a normal value and indicates that PRGO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.77, PRGO is in line with its industry, outperforming 41.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 1.77

3

3. Growth

3.1 Past

PRGO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.81%.
Measured over the past years, PRGO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.69% on average per year.
PRGO shows a decrease in Revenue. In the last year, the revenue decreased by -5.63%.
Measured over the past years, PRGO shows a decrease in Revenue. The Revenue has been decreasing by -0.32% on average per year.
EPS 1Y (TTM)0.81%
EPS 3Y-14.79%
EPS 5Y-10.69%
EPS Q2Q%26.56%
Revenue 1Y (TTM)-5.63%
Revenue growth 3Y4.43%
Revenue growth 5Y-0.32%
Sales Q2Q%-3.23%

3.2 Future

The Earnings Per Share is expected to grow by 8.11% on average over the next years. This is quite good.
Based on estimates for the next years, PRGO will show a small growth in Revenue. The Revenue will grow by 1.54% on average per year.
EPS Next Y2.2%
EPS Next 2Y11.02%
EPS Next 3Y10.3%
EPS Next 5Y8.11%
Revenue Next Year-4.98%
Revenue Next 2Y-0.35%
Revenue Next 3Y0.94%
Revenue Next 5Y1.54%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.34, which indicates a very decent valuation of PRGO.
91.10% of the companies in the same industry are more expensive than PRGO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.20. PRGO is valued rather cheaply when compared to this.
PRGO is valuated reasonably with a Price/Forward Earnings ratio of 8.10.
PRGO's Price/Forward Earnings ratio is rather cheap when compared to the industry. PRGO is cheaper than 91.62% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PRGO to the average of the S&P500 Index (23.73), we can say PRGO is valued rather cheaply.
Industry RankSector Rank
PE 10.34
Fwd PE 8.1

4.2 Price Multiples

82.72% of the companies in the same industry are more expensive than PRGO, based on the Enterprise Value to EBITDA ratio.
83.25% of the companies in the same industry are more expensive than PRGO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.16
EV/EBITDA 11.95

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRGO does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.69
PEG (5Y)N/A
EPS Next 2Y11.02%
EPS Next 3Y10.3%

6

5. Dividend

5.1 Amount

PRGO has a Yearly Dividend Yield of 4.29%, which is a nice return.
PRGO's Dividend Yield is rather good when compared to the industry average which is at 4.42. PRGO pays more dividend than 95.81% of the companies in the same industry.
PRGO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 4.29%

5.2 History

The dividend of PRGO is nicely growing with an annual growth rate of 7.88%!
PRGO has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of PRGO decreased recently.
Dividend Growth(5Y)7.88%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

The earnings of PRGO are negative and hence is the payout ratio. PRGO will probably not be able to sustain this dividend level.
The dividend of PRGO is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-94.24%
EPS Next 2Y11.02%
EPS Next 3Y10.3%

PERRIGO CO PLC

NYSE:PRGO (12/20/2024, 8:04:00 PM)

After market: 25.75 0 (0%)

25.75

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners98.96%
Inst Owner Change2.63%
Ins Owners0.36%
Ins Owner Change-4.45%
Market Cap3.51B
Analysts81.82
Price Target36.72 (42.6%)
Short Float %2.96%
Short Ratio2.63
Dividend
Industry RankSector Rank
Dividend Yield 4.29%
Dividend Growth(5Y)7.88%
DP-94.24%
Div Incr Years1
Div Non Decr Years1
Ex-Date11-29 2024-11-29 (0.276)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.84%
Min EPS beat(2)-2.11%
Max EPS beat(2)13.78%
EPS beat(4)3
Avg EPS beat(4)9.12%
Min EPS beat(4)-2.11%
Max EPS beat(4)23.61%
EPS beat(8)7
Avg EPS beat(8)8.67%
EPS beat(12)8
Avg EPS beat(12)2.4%
EPS beat(16)8
Avg EPS beat(16)-2.85%
Revenue beat(2)0
Avg Revenue beat(2)-5.94%
Min Revenue beat(2)-7.19%
Max Revenue beat(2)-4.69%
Revenue beat(4)0
Avg Revenue beat(4)-4.6%
Min Revenue beat(4)-7.19%
Max Revenue beat(4)-2.95%
Revenue beat(8)0
Avg Revenue beat(8)-4.3%
Revenue beat(12)1
Avg Revenue beat(12)-3.2%
Revenue beat(16)1
Avg Revenue beat(16)-4.49%
PT rev (1m)-0.69%
PT rev (3m)-6.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.3%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 10.34
Fwd PE 8.1
P/S 0.8
P/FCF 23.16
P/OCF 13.56
P/B 0.77
P/tB N/A
EV/EBITDA 11.95
EPS(TTM)2.49
EY9.67%
EPS(NY)3.18
Fwd EY12.35%
FCF(TTM)1.11
FCFY4.32%
OCF(TTM)1.9
OCFY7.37%
SpS32.19
BVpS33.47
TBVpS-11.11
PEG (NY)4.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.43%
ROE -3.5%
ROCE 2.44%
ROIC 1.93%
ROICexc 2.27%
ROICexgc 8.52%
OM 5.42%
PM (TTM) N/A
GM 36.07%
FCFM 3.45%
ROA(3y)-0.68%
ROA(5y)-0.44%
ROE(3y)-1.5%
ROE(5y)-0.97%
ROIC(3y)3.16%
ROIC(5y)2.69%
ROICexc(3y)3.77%
ROICexc(5y)3.1%
ROICexgc(3y)14.82%
ROICexgc(5y)11.94%
ROCE(3y)4%
ROCE(5y)3.4%
ROICexcg growth 3Y12.9%
ROICexcg growth 5Y-9.57%
ROICexc growth 3Y5.16%
ROICexc growth 5Y-9.15%
OM growth 3Y-2.94%
OM growth 5Y-9.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.43%
GM growth 5Y-1.39%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 31.33
Debt/EBITDA 7.57
Cap/Depr 32.37%
Cap/Sales 2.44%
Interest Coverage 250
Cash Conversion 45.49%
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 1.77
Altman-Z 0.75
F-Score3
WACC6.46%
ROIC/WACC0.3
Cap/Depr(3y)42.7%
Cap/Depr(5y)50.77%
Cap/Sales(3y)3.24%
Cap/Sales(5y)4.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.81%
EPS 3Y-14.79%
EPS 5Y-10.69%
EPS Q2Q%26.56%
EPS Next Y2.2%
EPS Next 2Y11.02%
EPS Next 3Y10.3%
EPS Next 5Y8.11%
Revenue 1Y (TTM)-5.63%
Revenue growth 3Y4.43%
Revenue growth 5Y-0.32%
Sales Q2Q%-3.23%
Revenue Next Year-4.98%
Revenue Next 2Y-0.35%
Revenue Next 3Y0.94%
Revenue Next 5Y1.54%
EBIT growth 1Y0.25%
EBIT growth 3Y1.36%
EBIT growth 5Y-10.03%
EBIT Next Year40.56%
EBIT Next 3Y19.53%
EBIT Next 5Y12.88%
FCF growth 1Y243.11%
FCF growth 3Y-10.98%
FCF growth 5Y-7.75%
OCF growth 1Y1518.75%
OCF growth 3Y-13.94%
OCF growth 5Y-7.32%